Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

908 Devices’ Research Partner Presents Research on Mass Spectrometry

Published: Friday, August 16, 2013
Last Updated: Friday, August 16, 2013
Bookmark and Share
Advancing the rapidly evolving field of High Pressure Mass Spectrometry.

908 Devices continues to benefit from its research partnership with the group of Prof. J. Michael Ramsey at the University of North Carolina at Chapel Hill (UNC-CH).

The Ramsey team made a total of eight research presentations at the American Society of Mass Spectrometry Conference in June, all advancing the rapidly evolving field of High Pressure Mass Spectrometry (HPMS™).

The UNC-CH presentations covered substantial advances in both the theoretical understanding and practical performance of miniature ion traps, ionizers and detectors at operating pressures up to, and beyond, 1 torr - HPMS™.

Multiple presentations explored the theoretical attributes of ion trajectories as a function of trap fabrication geometries and drive parameters.

One of the most exciting areas of research involves a new stretched length ion trap geometry that experimentally demonstrated a near order-of-magnitude increase in ion-trapping capacities compared to cylindrical geometries.

Further, a presentation on the influence of drive frequency demonstrated sub-amu resolutions from miniature ion trap arrays operating in the HPMS regime.

908 Devices has exclusive license to a broad portfolio of patents developed by the research team at the University that contributes to the design and manufacture of simple-to-operate, ultra-compact chemical detection and analysis tools.

The HPMS™ projects presented by the Ramsey group received support from the US Department of Defense (DOD) signifying the value placed on these capabilities by the safety and security community.

Dr. Chris Brown, Co-founder and CTO of 908 Devices highlighted the impressive nature of the research presented by saying, “The Ramsey group at UNC-CH has a large, focused and productive effort in the field of miniaturized mass spectrometry. Collaboration between our teams continues to be mutually beneficial and we are extremely excited about working together to successfully bring the powerful capabilities of mass spectrometry out of the laboratory into the hands of the first responder.”

These HPMS developments are crucial to the successful creation of highly sensitive and selective miniaturized mass spectrometry tools by 908 Devices.

The initial product focus is on safety and security markets, but the broad platform of 908 Devices’ simple, rugged and cost-effective MS analyzers will address customer problems across diverse markets.

The UNC-CH research team is led by Professor J. Michael Ramsey, who is the Minnie N. Gold by Distinguished Professor of Chemistry in UNC-CH’s College of Arts and Sciences, at the University with additional multiple appointments in the UNC-CH School of Medicine.

Prof. Ramsey is also a co-founder of 908 Devices, a member of its Board of Directors and the Science Founder of Caliper Life Sciences.

“Our presentations outlined clearly a number of innovative advances in miniaturized mass spectrometry, a dynamic field with myriad practical applications outside the lab,” said Prof. Ramsey.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

908 Devices Announces Significant Milestones
Company has expanded its office from a 7,000 square-foot R&D think tank into a 16,000 square-foot full-scale production facility.
Wednesday, August 20, 2014
908 Devices Receives $7 Million in Series B Funding
The financing round will be used to expand the R&D team and to accelerate and commercialize 908 Devices’ initial safety and security products.
Wednesday, September 11, 2013
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!